Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surgery With or Without Postoperative Hepatic Arterial Chemotherapy in HCC With Portal Vein Tumor Thrombus
NCT00238160Phase 3Withdrawn
- Sponsor
- Kyoto University
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluorouracil, cisplatin in hepatocellular carcinoma (HCC), sponsored by Kyoto University. Status: withdrawn.
02
Drugs
fluorouracilcisplatin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00238160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00238160.